Literature DB >> 24903215

Serum selenium deficiency in patients with hematological malignancies: is a supplementation study mandatory?

Ralph Muecke, Oliver Micke, Lutz Schomburg, Jens Buentzel, Irenaeus A Adamietz, Jutta Huebner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24903215     DOI： 10.1159/000360903

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  3 in total

Review 1.  Selenium in Radiation Oncology-15 Years of Experiences in Germany.

Authors:  Ralph Muecke; Oliver Micke; Lutz Schomburg; Jens Buentzel; Klaus Kisters; Irenaeus A Adamietz
Journal:  Nutrients       Date:  2018-04-13       Impact factor: 5.717

Review 2.  Therapeutic Benefits of Selenium in Hematological Malignancies.

Authors:  Melanie A Ehudin; Upendarrao Golla; Devnah Trivedi; Shobha D Potlakayala; Sairam V Rudrabhatla; Dhimant Desai; Sinisa Dovat; David Claxton; Arati Sharma
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

3.  Whole Blood Selenium Levels and Selenium Supplementation in Patients Treated in a Family Doctor Practice in Golßen (State of Brandenburg, Germany): A Laboratory Study.

Authors:  Ralph Muecke; Knut Waldschock; Lutz Schomburg; Oliver Micke; Jens Buentzel; Klaus Kisters; Irenaeus A Adamietz; Jutta Huebner
Journal:  Integr Cancer Ther       Date:  2018-10-25       Impact factor: 3.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.